World-Wide Webinar Series: Impact of Modeling & Simulation in Drug Development

This series aims to foster the use of Modeling and Simulation (M&S). Each session will demonstrate how M&S can support product discovery, development, or marketing programs. The series is intended for project team members, including pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinicians, regulatory affairs specialists, and Chief Medical and Scientific Officers.

Webinars are free, live sessions that include presentation and discussion sessions. Archived webinars


Oct 19, 2016

12:00-1:00 EDT


Nov 16, 2016

12:00-1:00 EST


  • TBD
  • Craig Thalhauser, Ph.D., Associate Director/Quantitative Clinical Pharmacology, Bristol-Myers Squibb, Princeton, NJ

Dec 14, 2016

12:00-1:00 EST


  • TBD
  • Ben-Fillippo Krippendorff, Ph.D.; Quantitative Systems Pharmacology, Pharmaceutical Sciences, Roche Pharma Research & Early Development, Roche Innovation Center Basel

Jan 18, 2017

12:00-1:00 EST


Feb 15, 2017

12:00-1:00 EST


  • TBD 
  • Stacey Tannenbaum, PhD, FISoP; Director: Pharmacokinetics, Modeling, and Simulation, Clinical Pharmacology & Exploratory Development; Astellas Pharma Global Development; Northbrook, IL

Apr 19, 2017

12:00-1:00 PM EDT


May 17 2017

1:00-2:00 PM EDT